These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 17060061

  • 1. Insulin resistance and blood pressure circadian variation in an obese hypertensive population.
    Diamantopoulos EJ, Andreadis E, Tsourous G, Katsanou P, Georgiopoulos D, Fotia M, Antoniou A, Raptis SA.
    Clin Exp Hypertens; 2006 Oct; 28(7):625-30. PubMed ID: 17060061
    [Abstract] [Full Text] [Related]

  • 2. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 3. [Reduced nocturnal systolic blood pressure dip in obese children].
    Ruiz Pons M, García Nieto V, García MG, García Mérida M, Valenzuela Hdez C, Aguirre-Jaime A.
    Nefrologia; 2008 Aug; 28(5):517-24. PubMed ID: 18816210
    [Abstract] [Full Text] [Related]

  • 4. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
    Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K, Umeno Y, Okada K, Wakasugi K, Yonemochi H, Eshima N, Saikawa T, Yoshimatsu H.
    Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
    [Abstract] [Full Text] [Related]

  • 5. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients.
    Della Mea P, Lupia M, Bandolin V, Guzzon S, Sonino N, Vettor R, Fallo F.
    Am J Hypertens; 2005 Jan; 18(1):30-5. PubMed ID: 15691614
    [Abstract] [Full Text] [Related]

  • 6. Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?
    Afsar B, Sezer S, Elsurer R, Ozdemir FN.
    Blood Press Monit; 2007 Jun; 12(3):133-9. PubMed ID: 17496462
    [Abstract] [Full Text] [Related]

  • 7. Association between nocturnal blood pressure dipping and insulin metabolism in obese adolescents.
    Westerståhl M, Marcus C.
    Int J Obes (Lond); 2010 Mar; 34(3):472-7. PubMed ID: 19752880
    [Abstract] [Full Text] [Related]

  • 8. Hypoadiponectinemia is associated with blood pressure increase in obese insulin-resistant individuals.
    Francischetti EA, Celoria BM, Duarte SF, da Silva EG, Santos IJ, Cabello PH, Genelhu VA.
    Metabolism; 2007 Nov; 56(11):1464-9. PubMed ID: 17950095
    [Abstract] [Full Text] [Related]

  • 9. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A, Khalilzadeh O, Abbasi M, Nakhjavani M, Novin L, Esteghamati AR.
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [Abstract] [Full Text] [Related]

  • 10. Ambulatory blood pressure monitoring in obese children: role of insulin resistance.
    Marcovecchio ML, Patricelli L, Zito M, Capanna R, Ciampani M, Chiarelli F, Mohn A.
    J Hypertens; 2006 Dec; 24(12):2431-6. PubMed ID: 17082726
    [Abstract] [Full Text] [Related]

  • 11. Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension.
    Tsioufis C, Syrseloudis D, Dimitriadis K, Thomopoulos C, Tsiachris D, Pavlidis P, Selima M, Kallikazaros I, Stefanadis C.
    J Hum Hypertens; 2008 Jul; 22(7):501-8. PubMed ID: 18385743
    [Abstract] [Full Text] [Related]

  • 12. Microvascular impairment is associated with insulin resistance in euglycemic mild hypertensives.
    Nazzaro P, Vulpis V, Schirosi G, Serio G, Battista L, Lucivero V, Livrea P, Federico F.
    Am J Hypertens; 2008 Apr; 21(4):432-7. PubMed ID: 18369361
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC.
    Chronobiol Int; 2007 Apr; 24(4):749-75. PubMed ID: 17701685
    [Abstract] [Full Text] [Related]

  • 15. Use of plasma B-type natriuretic peptide level to identify asymptomatic hypertensive patients with abnormal diurnal blood pressure variation profiles: nondippers, extreme dippers, and risers.
    Nakatsu T, Shinohata R, Mashima K, Yuki Y, Nishitani A, Toyonaga S, Ogawa H, Hirohata S, Usui S, Kusachi S.
    Hypertens Res; 2007 Jul; 30(7):651-8. PubMed ID: 17785934
    [Abstract] [Full Text] [Related]

  • 16. The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension.
    Tekes S, Cikim AS.
    J Hum Hypertens; 2007 Jul; 21(7):546-50. PubMed ID: 17392814
    [Abstract] [Full Text] [Related]

  • 17. Relationship of circadian blood pressure and morning blood pressure surge with the severity of metabolic syndrome in newly diagnosed hypertensives.
    Bastos JM, Bertoquini S, Polónia J.
    Rev Port Cardiol; 2007 Jul; 26(7-8):731-41. PubMed ID: 17939582
    [Abstract] [Full Text] [Related]

  • 18. Circadian blood pressure variation: relationship between dipper status and measures of arterial stiffness.
    Jerrard-Dunne P, Mahmud A, Feely J.
    J Hypertens; 2007 Jun; 25(6):1233-9. PubMed ID: 17563536
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M, König D, Frey I, Predel HG, Parhofer KG, Berg A.
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.